PubRank

Anita Langerød

Author PubWeight™ 104.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012 20.47
2 Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 2009 13.45
3 The landscape of cancer genes and mutational processes in breast cancer. Nature 2012 11.24
4 Mutational processes molding the genomes of 21 breast cancers. Cell 2012 11.22
5 The life history of 21 breast cancers. Cell 2012 10.59
6 Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 2011 5.62
7 Mutant p53 disrupts mammary tissue architecture via the mevalonate pathway. Cell 2012 4.09
8 Mutation of GATA3 in human breast tumors. Oncogene 2004 3.92
9 Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004 3.73
10 The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. Clin Cancer Res 2006 2.76
11 Discovery and validation of breast cancer subtypes. BMC Genomics 2006 1.83
12 EZH2 and BMI1 inversely correlate with prognosis and TP53 mutation in breast cancer. Breast Cancer Res 2008 1.42
13 CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Mol Oncol 2008 1.16
14 Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer 2007 1.12
15 Combining gene signatures improves prediction of breast cancer survival. PLoS One 2011 1.11
16 Functional characterization of the 19q12 amplicon in grade III breast cancers. Breast Cancer Res 2012 1.06
17 Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters. Mol Cancer 2006 1.04
18 Epithelial-stromal interaction 1 (EPSTI1) substitutes for peritumoral fibroblasts in the tumor microenvironment. Am J Pathol 2010 1.01
19 Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res 2007 1.01
20 BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations. BMC Cancer 2010 0.95
21 Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications. Clin Cancer Res 2005 0.94
22 Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev 2007 0.94
23 p53-Dependent repression of focal adhesion kinase in response to estradiol in breast cancer cell-lines. Cancer Lett 2010 0.88
24 Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution. Mol Oncol 2009 0.85
25 Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups. Breast Cancer Res Treat 2011 0.81
26 Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma. Open Virol J 2008 0.80
27 AZGP1 and SPDEF mRNA expression differentiates breast carcinoma from ovarian serous carcinoma. Virchows Arch 2012 0.80
28 Overexpression of cyclin A overrides the effect of p53 alterations in breast cancer patients with long follow-up time. Breast Cancer Res Treat 2003 0.79
29 AMG 900, pan-Aurora kinase inhibitor, preferentially inhibits the proliferation of breast cancer cell lines with dysfunctional p53. Breast Cancer Res Treat 2013 0.77